129 related articles for article (PubMed ID: 21188468)
1. The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.
Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
J Neurooncol; 2011 Sep; 104(2):611. PubMed ID: 21188468
[No Abstract] [Full Text] [Related]
2. Brain SPECT by 99mTc-tetrofosmin for the differentiation of tumor recurrence from radiation injury.
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
J Nucl Med; 2008 Oct; 49(10):1733-4; author reply 1734. PubMed ID: 18794274
[No Abstract] [Full Text] [Related]
3. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-tetrofosmin SPECT for glioma evaluation.
Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Polyzoidis KS; Fotopoulos AD
Mol Imaging Biol; 2009; 11(4):223. PubMed ID: 19326176
[No Abstract] [Full Text] [Related]
5. 99mTc-tetrofosmin SPECT for the evaluation of cerebral lesions.
Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2403-4. PubMed ID: 20821207
[No Abstract] [Full Text] [Related]
6. 99mTc-Tetrofosmin brain SPECT in prognostic assessment of high-grade gliomas.
Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
Radiother Oncol; 2008 Feb; 86(2):290. PubMed ID: 18207267
[No Abstract] [Full Text] [Related]
7. Discrimination between glioma recurrence and radiation-induced necrosis: in regards to Qing-Shi et al. (Int J Radiat Oncol Biol Phys 2007;68:151-158).
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1585-6; author reply 1586. PubMed ID: 17674998
[No Abstract] [Full Text] [Related]
8. Characterization of intracranial space-occupying lesions by ⁹⁹(m)Tc-Tetrofosmin SPECT.
Fotopoulos AD; Kyritsis AP; Tsiouris S; Al-Boucharali J; Papadopoulos A; Voulgaris S; Alexiou GA
J Neurooncol; 2011 Jan; 101(1):83-9. PubMed ID: 20496160
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m Tetrofosmin SPECT for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma.
Alexiou GA; Bokharhii JA; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
J Neurooncol; 2006 Jun; 78(2):207-8. PubMed ID: 16575536
[No Abstract] [Full Text] [Related]
10. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
11. In Reference to Alexiou et al. (Neuro-Oncology 2008;10:104-105). Evaluation of glioma proliferation by 99mTc-Tetrofosmin.
Beauchesne P
Neuro Oncol; 2008 Aug; 10(4):643. PubMed ID: 18577563
[No Abstract] [Full Text] [Related]
12. Scintigraphic assessment of recurrent glioma with focus on proliferation.
Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
Nucl Med Commun; 2008 Sep; 29(9):840-1. PubMed ID: 18677216
[No Abstract] [Full Text] [Related]
13. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
14. Imaging using Tc99m-tetrofosmin for the detection of the recurrence of brain tumour: a comparative study with Tc99m-glucoheptonate.
Barai S; Bandopadhayaya GP; Julka PK; Malhotra A; Bal CS; Dhanpathi H
J Postgrad Med; 2004; 50(2):89-93. PubMed ID: 15235200
[TBL] [Abstract][Full Text] [Related]
15. Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid camera.
Filippi L; Santoni R; Nicolì P; Danieli R; Schillaci O
Cancer Biother Radiopharm; 2009 Apr; 24(2):229-35. PubMed ID: 19409045
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1571-2. PubMed ID: 18491087
[No Abstract] [Full Text] [Related]
18. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
Alexiou GA; Tsiouris S; Kyritsis AP; Fotakopoulos G; Goussia A; Voulgaris S; Fotopoulos AD
J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of single photon emission computerised tomography (SPECT) using Tc99m-tetrofosmin as a diagnostic modality for recurrent posterior fossa tumours.
Barai S; Bandopadhayaya GP; Julka PK; Haloi AK; Seith A; Malhotra A
J Postgrad Med; 2003; 49(4):316-20; discussion 320-1. PubMed ID: 14699229
[TBL] [Abstract][Full Text] [Related]
20. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
